UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals

European journal of radiology, 2013-06, Vol.82 (6), p.959-968

2013

Volltextzugriff (PDF)

ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS5612-TPS5612

2021

Volltextzugriff (PDF)

A phase III, randomized, open label, multicenter, global study of first-line (1L) durvalumab in combination with standard of care (SOC) chemotherapy and durvalumab in combination with tremelimumab and SOC chemotherapy versus SOC chemotherapy alone in patients with unresectable locally advanced or metastatic urothelial cancer (UC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS4590-TPS4590

2019

Volltextzugriff (PDF)

POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.412-412

2021

Volltextzugriff (PDF)

A phase III, randomized, open label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine+cisplatin (G+C) for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (MIBC) (NIAGARA)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS4592-TPS4592

2019

Volltextzugriff (PDF)

POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16800-e16800

2020

Volltextzugriff (PDF)

SELECT-4: Phase I dose escalation trial of selumetinib (AZD6244, ARRY-142886) in combination with durvalumab (MEDI4736) in patients with advanced solid tumors

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS2607-TPS2607

2016

Volltextzugriff (PDF)

CNS response to osimertinib in patients (pts) with T790M-positive advanced NSCLC: Data from a randomized phase III trial (AURA3)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9005-9005

2017

Volltextzugriff (PDF)

Exploratory biomarker analysis of a phase I study of AZD4547, an inhibitor of fibroblast growth factor receptor (FGFR), in patients with advanced solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.11010-11010

2014

Volltextzugriff (PDF)

Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC

The New England journal of medicine, 2023-11, Vol.389 (21), p.1935-1948

2023

Volltextzugriff (PDF)

Enhancing Fraction Predicts Clinical Outcome following First-Line Chemotherapy in Patients with Epithelial Ovarian Carcinoma

Clinical cancer research, 2007-10, Vol.13 (20), p.6130-6135

2007

Volltextzugriff (PDF)

Role of computerized tomography in the diagnosis of transitional cell carcinoma of the upper urinary tract

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2003-07, Vol.107 (3), p.613-617

2003

Volltextzugriff (PDF)

Renal cell carcinoma- diagnosis by computed tomography

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2002-01, Vol.106 (1), p.65-69

2002

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(13)

Sprache

Englisch
(11)
Rumänisch
(2)

Erscheinungsjahr

n.n

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals

ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma

POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC)

A phase III, randomized, open label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine+cisplatin (G+C) for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (MIBC) (NIAGARA)

POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC)

SELECT-4: Phase I dose escalation trial of selumetinib (AZD6244, ARRY-142886) in combination with durvalumab (MEDI4736) in patients with advanced solid tumors

CNS response to osimertinib in patients (pts) with T790M-positive advanced NSCLC: Data from a randomized phase III trial (AURA3)

Exploratory biomarker analysis of a phase I study of AZD4547, an inhibitor of fibroblast growth factor receptor (FGFR), in patients with advanced solid tumors

Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC

Enhancing Fraction Predicts Clinical Outcome following First-Line Chemotherapy in Patients with Epithelial Ovarian Carcinoma

Role of computerized tomography in the diagnosis of transitional cell carcinoma of the upper urinary tract

Renal cell carcinoma- diagnosis by computed tomography

Suchergebnisse filtern